JPRN-UMIN000009567已完成未知
Evaluation of efficacy of Sitafloxacin in treatment of moderate to severe acute rhinosinusitis - Evaluation of efficacy of Sitafloxacin in treatment of moderate to severe acute rhinosinusitis
Wakayama-Okayama Otolaryngology Pharma0 个研究点目标入组 100 人开始时间: 2012年12月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with history of hypersensitivity to quinolone (2) Patients with history of convulsive disorder (e.g. Epilepsy) (3)Pregnant or lactating women (4)Severe heart diseases or hepatic dysfunction (5) Moderate or severe renal dysfunction (6) Severe underlying disease; patients in which clinical evaluation is difficult because of confounding diseases (7) Patients showing improvement of symptoms by the other antibiotic therapy (8) Administration of Sitafloxacin 7 days before starting Sitafloxacin (9)For other reasons, patients determined to be inappropriate for study entry by investigator
研究者
相似试验
招募中
不适用
Efficacy of sitafloxacin for urinary tract infectioJPRN-jRCTs061200052Takehiro Iwata92
已完成
2 期
Efficacy and safety of sitafloxacin (STFX) for low-risk febrile neutropenia in patients with lung cancer, phase II study,JPRN-UMIN000010911ung Oncology Group in Kyushu, Japan (LOGIK)54
已完成
不适用
Efficacy and safety of sitafloxacin (STFX) in tonsillar abcess; prospective study in outpatient setting.peritonsillar abcessJPRN-UMIN000013812Saitama Medical University20
已完成
不适用
Clinical trial of sitafloxacin against non-gonococcal urethritison-gonococcal urethritisJPRN-UMIN000004509PO CREC net500
已完成
2 期
Efficacy of sitafloxacin as third-line eradication treatment of Helicobacter pyloriH. pylori infectionJPRN-UMIN000004778ational Organization Tokyo medical center30